|
ACAA2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.604100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.192420E-01 |
| Normal-vs-Stage2 |
8.357200E-04 |
| Normal-vs-Stage3 |
1.32740000002851E-06 |
| Normal-vs-Stage4 |
1.71540000004633E-06 |
| Stage1-vs-Stage2 |
1.355580E-02 |
| Stage1-vs-Stage3 |
3.54870000000007E-05 |
| Stage1-vs-Stage4 |
1.5814599999997E-05 |
| Stage2-vs-Stage3 |
3.108000E-01 |
| Stage2-vs-Stage4 |
9.774100E-02 |
| Stage3-vs-Stage4 |
3.948400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.183900E-04 |
| Normal-vs-AfricanAmerican |
3.516700E-03 |
| Normal-vs-Asian |
9.242800E-03 |
| Caucasian-vs-AfricanAmerican |
6.869000E-01 |
| Caucasian-vs-Asian |
2.303600E-01 |
| AfricanAmerican-vs-Asian |
2.907200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.53040049919196E-10 |
| Normal-vs-Female |
9.236600E-01 |
| Male-vs-Female |
5.68749491947074E-11 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.56929999999678E-05 |
| Normal-vs-Age(41-60Yrs) |
9.571300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.022400E-03 |
| Normal-vs-Age(81-100Yrs) |
4.743200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.231700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.184500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.564270E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.967400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.048200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.536600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.965200E-01 |
| Normal-vs-Grade 2 |
1.674580E-01 |
| Normal-vs-Grade 3 |
9.966699999997E-05 |
| Normal-vs-Grade 4 |
1.74327219326642E-12 |
| Grade 1-vs-Grade 2 |
1.121590E-01 |
| Grade 1-vs-Grade 3 |
3.323500E-03 |
| Grade 1-vs-Grade 4 |
1.1218999951268E-08 |
| Grade 2-vs-Grade 3 |
1.217980E-03 |
| Grade 2-vs-Grade 4 |
3.99680288865056E-14 |
| Grade 3-vs-Grade 4 |
1.90529999999356E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.985600E-02 |
| Normal-vs-ccB subtype |
1.62647673107585E-12 |
| ccA subtype-vs-ccB subtype |
1.62447832963153E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.856510E-03 |
| Normal-vs-N1 |
4.45690000000498E-05 |
| N0-vs-N1 |
2.365600E-02 |
|
|
